Dianthus Therapeutics (DNTH) Misses Q1 EPS by 85c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 EPS of ($0.85). Revenue for the quarter came in at $460 thousand.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• SanDisk and Micron surge as Apple confirms memory price pass-through
• Grizzly Discoveries closes private placement raising $349,044